Neurocrine Biosciences Inc (NBIX)
Payables turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 929,000 | 891,900 | 868,900 | 823,200 | 776,400 | 731,600 | 698,000 | 656,700 | 583,300 | 536,300 | 492,700 | 445,300 | 431,200 | 427,750 | 397,039 | 380,571 | 353,004 | 328,943 | 306,406 | 285,743 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2023 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $929,000K ÷ $—K
= —
As the table does not provide specific data on Neurocrine Biosciences, Inc.'s payables turnover for the quarters indicated, it is not possible to calculate or analyze the payables turnover ratio for the company during these periods. The payables turnover ratio is a key liquidity metric that measures how efficiently a company is managing its payments to suppliers. A high payables turnover ratio generally suggests that a company is paying its suppliers quickly, while a low ratio may indicate delayed payments or potentially strained relationships with suppliers. To perform a meaningful analysis of Neurocrine Biosciences, Inc.'s payables turnover, specific data for each quarter would be necessary.
Peer comparison
Dec 31, 2023